Virtual Network's Login.
ESH Gold Institutional Partner
ESH Gold Institutional Partner
ESH Gold Institutional Partner
8th Translational Research Conference
Multiple Myeloma
March 26-28, 2026
#ESHMM2026
Stockholm Sweden
Chairs: Hartmut Goldschmidt, Martin Kaiser, Suzanne Lentzsch
REGISTRATION AND ABSTRACT SUBMISSION ARE OPEN
ABOUT THE CONFERENCE:
An outstanding faculty of myeloma experts will present the most recent advances and perspectives in the field of plasma disorders from pathophysiology to diagnosis and therapy.
The plenary conference program is designed to place emphasis on leading-edge basic and clinical research. The presentation of unpublished data is encouraged. Ample time is deliberately provided for in-depth scientific discussion and interaction.
Registered participants will further benefit from a variety of opportunities for informal scientific interaction with the world’s leading experts in the field, including during small Meet the Expert sessions and Mentored Posters Walks. Registered participants are invited to submit their biology and clinical abstracts. Selected abstracts will be presented as brief oral communications or posters.
MAIN SCIENTIFIC TOPICS
– MGUS
– Smouldering myeloma
– Characterising multiple myeloma
– Newly-diagnosed fit multiple myeloma
– Role of frailty for treatment decisions
– Personalising treatment in multiple myeloma
– Relapsed multiple myeloma
– Novel technologies for tailored treatment
– Amyloidosis and Weldenstrom’s Disease
THE PROGRAMME WILL INCLUDE:
– Plenary Sessions
– Panel Discussions
– Debates
– Poster Walks
– Simultaneous Meet the Expert Sessions
– Ample time for in-depth discussion
For more information on this conference, please contact Stephen Soriano
This conference is a Face to Face meeting. No virtual attendance is scheduled.
Click HERE to read the preliminary programme!
Abstracts are eligible to be selected for an oral or a poster presentation.
DEADLINE: JANUARY 5th, 2026
Guidelines for your abstract submission:
1. Your abstract should be structured (e.g. Objectives, Methods, Results, Conclusions)
2. Maximum number of words: 500
3. Your abstract will be submitted to the peer review procedure.
We accept “encore” abstract.
Presentation of data at this conference will not jeopardize acceptance of the same at the following ASH congress.
To book your accommodation a preferential, please click HERE after registering.
Clarion Hotel Stockholm
Ringvägen 98, 118 60 Stockholm, Sweden
The registration fee for the ESH 8th Translational Research Conference: Multiple Myeloma is:
– 600€ for fully trained
– 300€ for in-training *
– 300€ Allied Health Professionals
– 600€ for Corporate
*A proof will be requested to confirm your status.
ESH is pleased to offer BHS, BSH, DGHO, HSH, OeGHO, PTHiT, SEHH, SFH (French), SFH (Swedish) & SPH Members a 20% discount on the conference registration fees.
This fee includes:
– Your seat in the Conference Room
– The conference materials,
– Welcome cocktail, luncheons, refreshments throughout the conference.
Your seat in the conference will be definitively reserved upon receipt of your fee.
Cancellation policy of registration fee:
In case of cancellation, up until two months prior to the beginning of the meeting, your registration fee will be reimbursed in full (less bank charges). If the cancellation is notified between 60 to 15 days prior to the beginning of the meeting, 50% of the registration fee will be reimbursed (less bank charges). Cancellations notified 15 days before the meeting will not be reimbursed. For credit card payments please register on-line first. Please note that ESH can accept VISA and MASTERCARD/EUROCARD.
